Retraction of “Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway”

Detalles Bibliográficos
Autores principales: Lu, Jianqin, Liu, Xiangsheng, Liao, Yu-Pei, Wang, Xiang, Ahmed, Ayman, Jiang, Wen, Ji, Ying, Meng, Huan, Nel, Andre E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887877/
https://www.ncbi.nlm.nih.gov/pubmed/34018715
http://dx.doi.org/10.1021/acsnano.0c08653
_version_ 1784660996721213440
author Lu, Jianqin
Liu, Xiangsheng
Liao, Yu-Pei
Wang, Xiang
Ahmed, Ayman
Jiang, Wen
Ji, Ying
Meng, Huan
Nel, Andre E.
author_facet Lu, Jianqin
Liu, Xiangsheng
Liao, Yu-Pei
Wang, Xiang
Ahmed, Ayman
Jiang, Wen
Ji, Ying
Meng, Huan
Nel, Andre E.
author_sort Lu, Jianqin
collection PubMed
description
format Online
Article
Text
id pubmed-8887877
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-88878772022-03-02 Retraction of “Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway” Lu, Jianqin Liu, Xiangsheng Liao, Yu-Pei Wang, Xiang Ahmed, Ayman Jiang, Wen Ji, Ying Meng, Huan Nel, Andre E. ACS Nano American Chemical Society 2021-05-21 2021-06-22 /pmc/articles/PMC8887877/ /pubmed/34018715 http://dx.doi.org/10.1021/acsnano.0c08653 Text en © 2021 American Chemical Society https://pubs.acs.orgThis is an open-access article distributed under the ACS AuthorChoice Terms & Conditions. Any use of this article, must conform to the terms of that license which are available at https://pubs.acs.org.
spellingShingle Lu, Jianqin
Liu, Xiangsheng
Liao, Yu-Pei
Wang, Xiang
Ahmed, Ayman
Jiang, Wen
Ji, Ying
Meng, Huan
Nel, Andre E.
Retraction of “Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway”
title Retraction of “Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway”
title_full Retraction of “Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway”
title_fullStr Retraction of “Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway”
title_full_unstemmed Retraction of “Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway”
title_short Retraction of “Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway”
title_sort retraction of “breast cancer chemo-immunotherapy through liposomal delivery of an immunogenic cell death stimulus plus interference in the ido-1 pathway”
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887877/
https://www.ncbi.nlm.nih.gov/pubmed/34018715
http://dx.doi.org/10.1021/acsnano.0c08653
work_keys_str_mv AT lujianqin retractionofbreastcancerchemoimmunotherapythroughliposomaldeliveryofanimmunogeniccelldeathstimulusplusinterferenceintheido1pathway
AT liuxiangsheng retractionofbreastcancerchemoimmunotherapythroughliposomaldeliveryofanimmunogeniccelldeathstimulusplusinterferenceintheido1pathway
AT liaoyupei retractionofbreastcancerchemoimmunotherapythroughliposomaldeliveryofanimmunogeniccelldeathstimulusplusinterferenceintheido1pathway
AT wangxiang retractionofbreastcancerchemoimmunotherapythroughliposomaldeliveryofanimmunogeniccelldeathstimulusplusinterferenceintheido1pathway
AT ahmedayman retractionofbreastcancerchemoimmunotherapythroughliposomaldeliveryofanimmunogeniccelldeathstimulusplusinterferenceintheido1pathway
AT jiangwen retractionofbreastcancerchemoimmunotherapythroughliposomaldeliveryofanimmunogeniccelldeathstimulusplusinterferenceintheido1pathway
AT jiying retractionofbreastcancerchemoimmunotherapythroughliposomaldeliveryofanimmunogeniccelldeathstimulusplusinterferenceintheido1pathway
AT menghuan retractionofbreastcancerchemoimmunotherapythroughliposomaldeliveryofanimmunogeniccelldeathstimulusplusinterferenceintheido1pathway
AT nelandree retractionofbreastcancerchemoimmunotherapythroughliposomaldeliveryofanimmunogeniccelldeathstimulusplusinterferenceintheido1pathway

Ejemplares similares